Bøker av Stefano Fanti

This new atlas, the fourth of a successful series, is a completely revised and updated edition of a previously published FDG PET-CT atlas.

The field of nuclear medicine has evolved rapidly in recent years, and one very important aspect of this progress has been the introduction of hybrid imaging systems. PET-CT has already gained widespread acceptance in many clinical settings, especially within oncology, and now SPECT-CT promises to emulate its success.

Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. This atlas, including about 500 high-quality images, is a user-friendly guide to PET-CT imaging beyond FDG.